Clinical Trial Update: Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating intratympanic platelet-rich plasma for sensorineural hearing loss in Phase 2/3, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss
• Sudden Hearing Loss

Drugs mentioned

• Platelet-rich plasma (PRP)

Snippet

Sponsor: Assiut University | Conditions: Hearing Loss, Sudden, Hearing Loss, Sensorineural | Phase 2, Phase 3 | Status: UNKNOWN